GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dynatronics Corp (NAS:DYNT) » Definitions » Risk Assessment

Dynatronics (Dynatronics) Risk Assessment


View and export this data going back to 1994. Start your Free Trial

What is Dynatronics Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dynatronics is: High Risk: High uncertainty.


Competitive Comparison of Dynatronics's Risk Assessment

For the Medical Devices subindustry, Dynatronics's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynatronics's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynatronics's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dynatronics's Risk Assessment falls into.



Dynatronics  (NAS:DYNT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Dynatronics Risk Assessment Related Terms

Thank you for viewing the detailed overview of Dynatronics's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Dynatronics (Dynatronics) Business Description

Traded in Other Exchanges
N/A
Address
1200 Trapp Road, Eagan, MN, USA, 55121
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
Executives
Gabriel Ellwein officer: Chief Financial Officer 4782 HIGHCROFT COURT, EAGAN MN 55122
John Anthony Krier director, officer: Chief Executive Officer 319 WEST 50TH SOUTH, MINNEAPOLIS MN 55419
David B Holtz director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Scott Klosterman director
R Scott Ward director 1064 S. CRESTVIEW CIRCLE, SLC VA 84108
Stuart Essig 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Erin S. Enright director 666 PLAINSBORO ROAD, PLAINSBORO NJ 08536
Brian Larkin director INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Brian D. Baker officer: Chief Operating Officer C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Provco Ventures 1 Lp 10 percent owner 795 E LANCASTER AVE SUITE 200, VILLANOVA PA 19085
Norman Iii Roegner officer: Chief Financial Officer 1200 TRAPP ROAD, EAGAN MN 55121
Skyler N Black officer: Corporate Controller 1448 E LEXI LN, COTTONWOOD HEIGHTS UT 84093
Keeler Jennifer Bennett Bennett officer: Secretary / General Counsel 8620 STILLWATER BLVD N, LAKE ELMO MN 55042
Daryl Connell officer: Chief Information Officer 932 MINJON DRIVE, APPLE VALLEY MN 55124
Cynthia L. Mchenry officer: VP, Operations 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT 84121